Jacob Glanville

Jacob Glanville is a bioengineer and immunologist, and the founder of Centivax, on a mission to create a universal flu vaccine. They dive into the urgency of developing a vaccine that can protect against all flu strains, even future mutations. Glanville discusses innovative research techniques and collaborative efforts to tackle the challenges in vaccine technology. He also highlights the potential impacts on global health and the broader fight against pandemics, sharing insights on fundraising hurdles faced in the biotech industry.